(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione

C23H21IN4O2 — CID 70670653

IUPAC(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione
SMILESC=CC[C@H]1NC(=O)N([C@@H](Cc2ccccc2)c2ncc(-c3ccc(I)cc3)[nH]2)C1=O
InChIInChI=1S/C23H21IN4O2/c1-2-6-18-22(29)28(23(30)27-18)20(13-15-7-4-3-5-8-15)21-25-14-19(26-21)16-9-11-17(24)12-10-16/h2-5,7-12,14,18,20H,1,6,13H2,(H,25,26)(H,27,30)/t18-,20+/m1/s1
InChIKeyZINACVQVZUYJEM-QUCCMNQESA-N
MW512.35 g/mol
LogP4.46
Rot. Bonds7

About (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione

(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione (PubChem CID 70670653) has the molecular formula C23H21IN4O2 and a molecular weight of 512.35 g/mol. Its IUPAC name is (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione
PubChem CID70670653
Molecular FormulaC23H21IN4O2
Molecular Weight512.35 g/mol
Exact Mass512.07
IUPAC Name(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione
SMILESC=CC[C@H]1NC(=O)N([C@@H](Cc2ccccc2)c2ncc(-c3ccc(I)cc3)[nH]2)C1=O
InChIInChI=1S/C23H21IN4O2/c1-2-6-18-22(29)28(23(30)27-18)20(13-15-7-4-3-5-8-15)21-25-14-19(26-21)16-9-11-17(24)12-10-16/h2-5,7-12,14,18,20H,1,6,13H2,(H,25,26)(H,27,30)/t18-,20+/m1/s1
InChIKeyZINACVQVZUYJEM-QUCCMNQESA-N
XLogP4.46
TPSA78.09 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500512.35
LogP ≤ 54.46
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione?
The IUPAC name of (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione (CID 70670653) is (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione.
What is the SMILES notation for (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione?
The canonical SMILES for (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione is C=CC[C@H]1NC(=O)N([C@@H](Cc2ccccc2)c2ncc(-c3ccc(I)cc3)[nH]2)C1=O.
What is the InChIKey of (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione?
The InChIKey is ZINACVQVZUYJEM-QUCCMNQESA-N. The full InChI is InChI=1S/C23H21IN4O2/c1-2-6-18-22(29)28(23(30)27-18)20(13-15-7-4-3-5-8-15)21-25-14-19(26-21)16-9-11-17(24)12-10-16/h2-5,7-12,14,18,20H,1,6,13H2,(H,25,26)(H,27,30)/t18-,20+/m1/s1.
What are the key properties of (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione?
(5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione has a molecular weight of 512.35 g/mol, XLogP of 4.46, 7 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-3-[(1S)-1-[5-(4-iodophenyl)-1H-imidazol-2-yl]-2-phenylethyl]-5-prop-2-enylimidazolidine-2,4-dione is sourced from PubChem (CID 70670653), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).